By the end of January 2022, almost ************ COVID-19 vaccine doses were manufactured in China, making the country by far the largest producer of COVID-19 vaccines globally. While most vaccines were for domestic use, a considerable portion of vaccines was exported via sales and donations, mainly to lower or middle-income countries. In comparison to western mRNA vaccines such as Comirnaty or Spikevax, inactivated COVID-19 vaccines developed by Sinovac and Sinopharm have a lower efficacy rate.

Biotech companies started clinical trials on potential treatments for COVID-19 just three months after the genetic sequence of the virus was made public. In comparison, companies entered clinical trials 20 months after the viral genome of the SARS coronavirus was sequenced.

A cure could take several more months Chinese authorities shared the genetic sequence for the SARS-CoV-2 virus in early January, allowing research groups to analyze how the virus infects human cells and makes people sick. Treatments are now in development; several have entered early clinical trials. Assuming all tests go well, a treatment for COVID-19 could still take up to 18 months before being approved for public use. New vaccines typically take years, and there is enormous pressure to make it safe and effective for all members of the diverse population.

Parallels with the SARS epidemic The SARS coronavirus was responsible for the outbreak of severe acute respiratory syndrome (SARS) that first affected humans in the Guangdong province of China in 2002. The official name for the coronavirus is SARS-CoV, which is very similar to the SARS-CoV-2 name chosen for the coronavirus that causes COVID-19 disease. While genetically related and believed to spread in similar ways, the two viruses are different. There were more than 8,000 reported cases of SARS before it was brought under control in 2003.

Context

COVID-19 is an infectious disease caused by a newly discovered strain of coronavirus, a type of virus known to cause respiratory infections in humans. This new strain was unknown before December 2019, when an outbreak of pneumonia of unidentified cause emerged in Wuhan, China.

Ever since the Covid-19 pandemic there has been quite a buzz in social media platforms and news sites regarding the need for COVID-19 Vaccine. As the number of people getting affected by Covid-19 has been increasing drastically. This data set brings you the twitter tweets made with the hashtag #CovidVaccine

Content

The tweets have #CovidVaccine hashtag. The collection started on 1/8/2020, and will be updated on a daily basis.

Information regarding the data

The data totally consists of 1 lakh+ records with 13 columns. The description of the features is given below | No |Columns | Descriptions | | -- | -- | -- | | 1 | user_name | The name of the user, as they’ve defined it. | | 2 | user_location | The user-defined location for this account’s profile. | | 3 | user_description | The user-defined UTF-8 string describing their account. | | 4 | user_created | Time and date, when the account was created. | | 5 | user_followers | The number of followers a account currently has. | | 6 | user_friends | The number of friends a account currently has. | | 7 | user_favourites | The number of favorites a account currently has | | 8 | user_verified | When true, indicates that the user has a verified account | | 9 | date | UTC time and date when the Tweet was created | | 10 | text | The actual UTF-8 text of the Tweet | | 11 | hashtags | All the other hashtags posted in the tweet along with #CovidVaccine | | 12 | source | Utility used to post the Tweet, Tweets from the Twitter website have a source value - web | | 13 | is_retweet | Indicates whether this Tweet has been Retweeted by the authenticating user. |

Inspiration

You can use this data to dive into the subjects that use this hashtag, look to the geographical distribution, evaluate sentiments, looks to trends.

According to a May 2021 survey in the Philippines, Sinovac Biotech was the most preferred coronavirus (COVID-19) brand by Filipino respondents. The brand, which was developed by a Chinese biopharmaceutical company, was chosen by ** percent of Filipinos. In comparison, ** percent of the respondents stated that they prefer the Pfizer-BioNTech vaccine brand. At the time of the survey, ** percent of the COVID-19 vaccines that arrived in the country were China's Sinovac followed by the United Kingdom's AstraZeneca.

Dataset contains: Latest worldwide vaccination status of all the countries till 08th Jan 2023.

Features: Country-Name of the country Pct. of population Vaccinated-Percentage of population Vaccinated Pct. of population Fully vaccinated-Percentage of population Fully vaccinated Additional Doses Per 100 people-Number of additional doses per 100 people Additional Doses Total-Number of total additional doses Doses administered Per 100 people-Number of vaccine doses administered per 100 people Total Doses administered-Total number of doses administered

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by a virus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, China, in December 2019.The disease quickly spread worldwide, resulting in the COVID-19 pandemic.

Vaccines save millions of lives each year and a COVID-19 vaccine could save yours. The COVID-19 vaccines are safe and effective, providing strong protection against serious illness and death. WHO reports that unvaccinated people have at least 10 times higher risk of death from COVID-19 than someone who has been vaccinated.The COVID-19 vaccines are highly effective, but no vaccine provides 100 per cent protection. Some people will still get ill from COVID-19 after vaccination or pass the virus onto someone else. Therefore, it is important to continue practicing safety precautions to protect yourself and others, including avoiding crowded spaces, physical distancing, hand washing and wearing a mask.

As of June 27, 2022, around 93.7 million doses of Pfizer arrived in the Philippines. This was followed by Sinovac and AstraZeneca, with 56.11 million and 38.85 million vaccine doses, respectively.

COVID-19 vaccination in the Philippines started in March 2021.

Russia was to export 250 million doses of the coronavirus (COVID-19) vaccine Sputnik V to India, which was among the major planned producers of the vaccine. In total, Indian companies planned to produce at least 1,152 million doses of Sputnik V per year. Furthermore, Mexico ordered a total of 24 million doses of the vaccine. Sputnik V was authorized in more than 70 countries worldwide as of January 2022. Russia applied for the vaccine approval in the European Union in January 2021, while several EU countries approved its use earlier, such as Hungary or Slovakia.

Russia's first vaccine against COVID-19 In August 2020, Russia registered Sputnik V, the world’s first approved vaccine against COVID-19, which was developed at Gamaleya Research Institute in Moscow. After the third phase of clinical trials, the vaccine's effectiveness was measured at 91.6 percent. The mass vaccination in Russia started in January 2021. In December 2020, 30 percent of Russians would get vaccinated against COVID-19 with Sputnik V.
Is Sputnik V available abroad? In total, over 50 countries worldwide placed orders for Sputnik V from Russia. As of January 2021, The vaccine was used for vaccination in Russia, Belarus, Serbia. In October 2020, Russia applied for prequalification of Sputnik V at the WHO to speed up its availability worldwide. Other countries that would produce the vaccine, such as Brazil, China, India, or the Republic of Korea, would also sell it abroad. Among several countries surveyed in November 2020, the highest level of awareness about Sputnik V was recorded in Mexico.

As of March 10, 2023, there have been 1.1 million deaths related to COVID-19 in the United States. There have been 101,159 deaths in the state of California, more than any other state in the country – California is also the state with the highest number of COVID-19 cases.

The vaccine rollout in the U.S. Since the start of the pandemic, the world has eagerly awaited the arrival of a safe and effective COVID-19 vaccine. In the United States, the immunization campaign started in mid-December 2020 following the approval of a vaccine jointly developed by Pfizer and BioNTech. As of March 22, 2023, the number of COVID-19 vaccine doses administered in the U.S. had reached roughly 673 million. The states with the highest number of vaccines administered are California, Texas, and New York.

Vaccines achieved due to work of research groups Chinese authorities initially shared the genetic sequence to the novel coronavirus in January 2020, allowing research groups to start studying how it invades human cells. The surface of the virus is covered with spike proteins, which enable it to bind to human cells. Once attached, the virus can enter the cells and start to make people ill. These spikes were of particular interest to vaccine manufacturers because they hold the key to preventing viral entry.

As of May 2, 2023, the outbreak of the coronavirus disease (COVID-19) had spread to almost every country in the world, and more than 6.86 million people had died after contracting the respiratory virus. Over 1.16 million of these deaths occurred in the United States.

Waves of infections Almost every country and territory worldwide have been affected by the COVID-19 disease. At the end of 2021 the virus was once again circulating at very high rates, even in countries with relatively high vaccination rates such as the United States and Germany. As rates of new infections increased, some countries in Europe, like Germany and Austria, tightened restrictions once again, specifically targeting those who were not yet vaccinated. However, by spring 2022, rates of new infections had decreased in many countries and restrictions were once again lifted.

What are the symptoms of the virus? It can take up to 14 days for symptoms of the illness to start being noticed. The most commonly reported symptoms are a fever and a dry cough, leading to shortness of breath. The early symptoms are similar to other common viruses such as the common cold and flu. These illnesses spread more during cold months, but there is no conclusive evidence to suggest that temperature impacts the spread of the SARS-CoV-2 virus. Medical advice should be sought if you are experiencing any of these symptoms.